Product Description
Overall, the global ACL/PCL reconstruction market was valued at approximately $1.2 billion in 2022. This is expected to increase over the forecast period at a CAGR of 7.3% to reach over $1.9 billion.
The full report suite on the global market for ACL/PCL reconstruction includes grafts and fixation devices.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2029, and Historical Data to 2019
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- Procedure Volumes
- Company Profiles, Product Portfolios and SWOT for Top Competitors
- COVID-19 Impact Analysis
PROCEDURE NUMBERS
In 2022, the vast majority of ACL/PCL reconstruction procedures were performed with autograft tissue. The average cost for ACL reconstruction surgery with autograft tissue is approximately $1,000 less than with allograft. On the one hand, a procedure with autograft tissue requires an additional surgery to harvest and prepare the tissue, also increasing the risk of morbidity and complications at the donor site.
GLOBAL ACL/PCL RECONSTRUCTION MARKET TRENDS
The market is driven by incidence rates. Knee-related injuries are some of the most common types of injuries in professional sports. Sports medicine manufacturers collaborate with professional sports associations to address the most up to date and clinically approved treatment options. This results in financial support for related research and development activities, clinical trials and studies, as well as educational programs and fellowships.
GLOBAL ACL/PCL RECONSTRUCTION MARKET SHARE INSIGHTS
Overall, within the global ACL/PCL market there are three dominant competitors: Arthrex, Smith & Nephew, and DePuy Synthes.
In 2022, Arthrex led the combined ACL/PCL reconstruction market. The company dominated each region of the global market. Arthrex’s strong presence in the ACL/PCL fixation device market was due to its leading position in the interference screw segment, with the BioComposite™, in addition to PLA, metal and PEEK interference screw products.
GLOBAL ACL/PCL RECONSTRUCTION MARKET SEGMENTATION SUMMARY
- Grafts Market
- Fixation Device Market
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2022 |
| Forecast Period | 2023-2029 |
| Historical Data | 2019-2022 |
| Quantitative Data | Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices |
| Qualitative Data | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.
Read more about iData’s 9-Step Research Methodology |
WHY CHOOSE IDATA?
- Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
